2024-01-012024-12-312024-12-31false10833705THE GROWTH STAGE LIMITED2025-01-1774909falseiso4217:GBPxbrli:pure108337052024-01-01108337052024-12-31108337052024-01-012024-12-31108337052023-01-01108337052023-12-31108337052023-01-012023-12-3110833705bus:SmallEntities2024-01-012024-12-3110833705bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3110833705bus:FullAccounts2024-01-012024-12-3110833705bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110833705core:WithinOneYear2024-12-3110833705core:AfterOneYear2024-12-3110833705core:WithinOneYear2023-12-3110833705core:AfterOneYear2023-12-3110833705core:ShareCapital2024-12-3110833705core:SharePremium2024-12-3110833705core:RevaluationReserve2024-12-3110833705core:OtherReservesSubtotal2024-12-3110833705core:RetainedEarningsAccumulatedLosses2024-12-3110833705core:ShareCapital2023-12-3110833705core:SharePremium2023-12-3110833705core:RevaluationReserve2023-12-3110833705core:OtherReservesSubtotal2023-12-3110833705core:RetainedEarningsAccumulatedLosses2023-12-3110833705core:LandBuildings2024-12-3110833705core:PlantMachinery2024-12-3110833705core:Vehicles2024-12-3110833705core:FurnitureFittings2024-12-3110833705core:OfficeEquipment2024-12-3110833705core:NetGoodwill2024-12-3110833705core:IntangibleAssetsOtherThanGoodwill2024-12-3110833705core:ListedExchangeTraded2024-12-3110833705core:UnlistedNon-exchangeTraded2024-12-3110833705core:LandBuildings2023-12-3110833705core:PlantMachinery2023-12-3110833705core:Vehicles2023-12-3110833705core:FurnitureFittings2023-12-3110833705core:OfficeEquipment2023-12-3110833705core:NetGoodwill2023-12-3110833705core:IntangibleAssetsOtherThanGoodwill2023-12-3110833705core:ListedExchangeTraded2023-12-3110833705core:UnlistedNon-exchangeTraded2023-12-3110833705core:LandBuildings2024-01-012024-12-3110833705core:PlantMachinery2024-01-012024-12-3110833705core:Vehicles2024-01-012024-12-3110833705core:FurnitureFittings2024-01-012024-12-3110833705core:OfficeEquipment2024-01-012024-12-3110833705core:NetGoodwill2024-01-012024-12-3110833705core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110833705core:ListedExchangeTraded2024-01-012024-12-3110833705core:UnlistedNon-exchangeTraded2024-01-012024-12-3110833705core:MoreThanFiveYears2024-01-012024-12-3110833705core:Non-currentFinancialInstruments2024-12-3110833705core:Non-currentFinancialInstruments2023-12-3110833705dpl:CostSales2024-01-012024-12-3110833705dpl:DistributionCosts2024-01-012024-12-3110833705core:LandBuildings2024-01-012024-12-3110833705core:PlantMachinery2024-01-012024-12-3110833705core:Vehicles2024-01-012024-12-3110833705core:FurnitureFittings2024-01-012024-12-3110833705core:OfficeEquipment2024-01-012024-12-3110833705dpl:AdministrativeExpenses2024-01-012024-12-3110833705core:NetGoodwill2024-01-012024-12-3110833705core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110833705dpl:GroupUndertakings2024-01-012024-12-3110833705dpl:ParticipatingInterests2024-01-012024-12-3110833705dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3110833705core:ListedExchangeTraded2024-01-012024-12-3110833705dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3110833705core:UnlistedNon-exchangeTraded2024-01-012024-12-3110833705dpl:CostSales2023-01-012023-12-3110833705dpl:DistributionCosts2023-01-012023-12-3110833705core:LandBuildings2023-01-012023-12-3110833705core:PlantMachinery2023-01-012023-12-3110833705core:Vehicles2023-01-012023-12-3110833705core:FurnitureFittings2023-01-012023-12-3110833705core:OfficeEquipment2023-01-012023-12-3110833705dpl:AdministrativeExpenses2023-01-012023-12-3110833705core:NetGoodwill2023-01-012023-12-3110833705core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110833705dpl:GroupUndertakings2023-01-012023-12-3110833705dpl:ParticipatingInterests2023-01-012023-12-3110833705dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3110833705core:ListedExchangeTraded2023-01-012023-12-3110833705dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3110833705core:UnlistedNon-exchangeTraded2023-01-012023-12-3110833705core:NetGoodwill2024-12-3110833705core:IntangibleAssetsOtherThanGoodwill2024-12-3110833705core:LandBuildings2024-12-3110833705core:PlantMachinery2024-12-3110833705core:Vehicles2024-12-3110833705core:FurnitureFittings2024-12-3110833705core:OfficeEquipment2024-12-3110833705core:AfterOneYear2024-12-3110833705core:WithinOneYear2024-12-3110833705core:ListedExchangeTraded2024-12-3110833705core:UnlistedNon-exchangeTraded2024-12-3110833705core:ShareCapital2024-12-3110833705core:SharePremium2024-12-3110833705core:RevaluationReserve2024-12-3110833705core:OtherReservesSubtotal2024-12-3110833705core:RetainedEarningsAccumulatedLosses2024-12-3110833705core:NetGoodwill2023-12-3110833705core:IntangibleAssetsOtherThanGoodwill2023-12-3110833705core:LandBuildings2023-12-3110833705core:PlantMachinery2023-12-3110833705core:Vehicles2023-12-3110833705core:FurnitureFittings2023-12-3110833705core:OfficeEquipment2023-12-3110833705core:AfterOneYear2023-12-3110833705core:WithinOneYear2023-12-3110833705core:ListedExchangeTraded2023-12-3110833705core:UnlistedNon-exchangeTraded2023-12-3110833705core:ShareCapital2023-12-3110833705core:SharePremium2023-12-3110833705core:RevaluationReserve2023-12-3110833705core:OtherReservesSubtotal2023-12-3110833705core:RetainedEarningsAccumulatedLosses2023-12-3110833705core:NetGoodwill2023-01-0110833705core:IntangibleAssetsOtherThanGoodwill2023-01-0110833705core:LandBuildings2023-01-0110833705core:PlantMachinery2023-01-0110833705core:Vehicles2023-01-0110833705core:FurnitureFittings2023-01-0110833705core:OfficeEquipment2023-01-0110833705core:AfterOneYear2023-01-0110833705core:WithinOneYear2023-01-0110833705core:ListedExchangeTraded2023-01-0110833705core:UnlistedNon-exchangeTraded2023-01-0110833705core:ShareCapital2023-01-0110833705core:SharePremium2023-01-0110833705core:RevaluationReserve2023-01-0110833705core:OtherReservesSubtotal2023-01-0110833705core:RetainedEarningsAccumulatedLosses2023-01-0110833705core:AfterOneYear2024-01-012024-12-3110833705core:WithinOneYear2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110833705core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3110833705core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3110833705core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3110833705core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3110833705core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3110833705bus:Director12024-01-012024-12-3110833705bus:Director22024-01-012024-12-311083370512024-01-012024-12-31

THE GROWTH STAGE LIMITED

Registered Number
10833705
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

THE GROWTH STAGE LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

ACTON, Andrew Simon
STEWART, Simon Grahame John

Registered Address

4th Floor 18 St Cross Street
London
EC1N 8UN

Registered Number

10833705 (England and Wales)
THE GROWTH STAGE LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Investments3227,009227,009
227,009227,009
Current assets
Debtors54,842148,562
Cash at bank and on hand230,599286,108
235,441434,670
Creditors amounts falling due within one year6(26,596)(155,077)
Net current assets (liabilities)208,845279,593
Total assets less current liabilities435,854506,602
Net assets435,854506,602
Capital and reserves
Called up share capital20,02620,026
Share premium180,967180,967
Other reserves(79,747)-
Profit and loss account314,608305,609
Shareholders' funds435,854506,602
The financial statements were approved and authorised for issue by the Board of Directors on 17 January 2025, and are signed on its behalf by:
STEWART, Simon Grahame John
Director
Registered Company No. 10833705
THE GROWTH STAGE LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Revenue from rendering of services
Turnover is usually recognised on completion of the service, and for monthly engagements, it is recognised by reference to the stage of completion at the balance sheet date.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: • Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. • Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. • If an arrangement constitutes a finance transaction it is measured at present value. • Shares in subsidiaries, associates and jointly controlled entities are included at cost. All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price, and are subsequently measured at fair value, with any changes recognised in profit or loss. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped based on similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year22
3.Fixed asset investments

Other investments1

Other loans2

Total

£££
Cost or valuation
At 01 January 2420,008207,001227,009
At 31 December 2420,008207,001227,009
Net book value
At 31 December 2420,008207,001227,009
At 31 December 2320,008207,001227,009

Notes

1Other investments other than loans
2Other loans classified under investments
4.Impairment of fixed asset investments
A review for indicators of impairment is conducted at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables-148,292
Other debtors4,842270
Total4,842148,562
Short-term debtors are measured at transaction price (which is usually the invoice price), less impairment losses for bad and doubtful debts.
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables24,05612,348
Taxation and social security2,5404,598
Accrued liabilities and deferred income-138,131
Total26,596155,077
Short term creditors are measured at transaction price (which is usually the invoice price).
7.Events after reporting date
At the date of signature of these financial statements there were no post balance sheet events (2023 – None).
8.Related party transactions
The amount outstanding at the balance sheet date in relation to advances to directors was £0 (2023 – £0).
9.Further information regarding the company's financial position
The company acquired its own shares from a shareholder during the year. These shares have not been cancelled and are held in treasury.